Cure rates exceed 90 percent when caught early
A cada outubro, o Brasil se veste de rosa como um lembrete coletivo de que o câncer de mama, embora comum, não precisa ser fatal. No Espírito Santo, a campanha deste ano carrega um número concreto e pesado: 790 mulheres devem ser diagnosticadas até o fim de 2020. A ciência oferece uma resposta clara — quando detectado cedo, a taxa de cura supera 90% — mas a pandemia criou um silêncio perigoso, afastando mulheres dos exames e dos tratamentos que podem salvar suas vidas.
- 790 mulheres no Espírito Santo devem receber um diagnóstico de câncer de mama em 2020, tornando a campanha Outubro Rosa mais urgente do que nunca.
- A pandemia agravou a crise: mulheres estão adiando tratamentos e evitando exames por medo de contrair o coronavírus nos serviços de saúde.
- O cirurgião Dr. Cleverson Gomes do Carmo Junior alerta que interromper o tratamento por conta própria é tão perigoso quanto a doença — qualquer decisão deve ser tomada com a equipe médica.
- Os fatores de risco são conhecidos — idade acima de 50 anos, histórico familiar, obesidade, sedentarismo e consumo de álcool — e compreendê-los é o primeiro passo para a prevenção.
- A recomendação é acessível: autoexame mensal a partir dos 21 anos e mamografia anual após os 40, práticas que transformam vigilância em sobrevivência.
Todo outubro, o Brasil se mobiliza em torno do Outubro Rosa — campanha que une educação, detecção precoce e acesso ao tratamento do câncer de mama. Neste ano, as autoridades de saúde do Espírito Santo enfrentam uma projeção difícil: cerca de 790 mulheres no estado devem ser diagnosticadas com a doença até o fim de 2020. O dado pesa, mas carrega também uma mensagem de esperança: quando detectado em estágio inicial, o câncer de mama tem taxa de cura superior a 90%, segundo o Instituto Oncoguia.
A pandemia, porém, criou uma crise dentro da crise. Mulheres já diagnosticadas estão adiando tratamentos por medo de se expor ao coronavírus, enquanto outras evitam até mesmo os exames preventivos. O cirurgião de mama Dr. Cleverson Gomes do Carmo Junior reconhece o temor, mas é enfático: suspender o tratamento por iniciativa própria é perigoso. Qualquer decisão de pausar ou continuar deve ser tomada em conjunto com a equipe médica responsável pelo caso.
Os fatores de risco são múltiplos e se acumulam ao longo da vida — idade acima de 50 anos, histórico familiar, consumo de álcool, excesso de peso abdominal, sedentarismo, menarca antes dos 12 anos ou menopausa após os 55. Não há uma causa única, mas um conjunto de condições que pode ser monitorado e, em parte, modificado.
A prevenção tem uma arquitetura simples: a partir dos 21 anos, autoexame mensal — preferencialmente uma semana após o início da menstruação — com atenção a nódulos, alterações na pele e secreções no mamilo. Consultas regulares ao ginecologista e, após os 40 anos, mamografia anual completam o protocolo. Em um ano em que ir ao médico exige coragem, seguir esse caminho pode ser o gesto mais importante que uma mulher faz por si mesma.
October arrives each year with a particular urgency in Brazil. Pink ribbons appear in storefronts and hospitals. The message is simple but consequential: breast cancer kills, but it doesn't have to. This year, as the nation observes Outubro Rosa—the annual awareness campaign—health officials in Espírito Santo are bracing for a difficult number. By the end of 2020, roughly 790 women in the state are expected to receive a breast cancer diagnosis.
The campaign itself has become a fixture of public health in Brazil, designed to do several things at once: educate women about risk factors, push them toward early detection, and expand access to diagnosis and treatment. The underlying logic is straightforward. Breast cancer is one of the most common malignancies affecting women worldwide. It is also, when caught early, highly survivable. The Instituto Oncoguia reports cure rates exceeding 90 percent when the disease is identified in its initial stages. Everything hinges on that word: early.
Dr. Cleverson Gomes do Carmo Junior, a breast surgeon, has watched the landscape shift this year. The pandemic has created a secondary crisis within the crisis. Women who have been diagnosed are delaying treatment out of fear of coronavirus exposure. Others are avoiding screening altogether. The doctor's message is measured but firm: yes, women with breast cancer need to take precautions against infection. But stopping treatment on one's own is dangerous. The decision to pause or continue must come from the medical team managing the case, not from fear alone.
The risk factors themselves are well documented. Age matters—women over 50 face higher risk. Family history matters. So does alcohol consumption, excess weight (particularly around the abdomen), physical inactivity, and the timing of menstruation. Women who began menstruating before age 12 or entered menopause after 55 carry elevated risk. There is no single cause, the doctor explains, but rather a constellation of factors that can accumulate over time.
What women can do is watch themselves. The recommendation is simple enough to state, harder to practice consistently. Beginning at age 21, women should perform self-examination at least once monthly, ideally about a week after menstruation begins, when breast tissue is softer and less tender. They should feel for lumps, check for dimpling or waviness in the skin, and watch for any discharge from the nipple. Regular visits to a gynecologist are essential. And after age 40, annual mammography becomes part of the routine.
This is the architecture of prevention: awareness, self-knowledge, professional oversight, and early intervention. It works. The numbers prove it. But it requires women to show up—to their own bodies, to their doctors, and to the system designed to catch disease before it becomes catastrophic. In a year when showing up feels dangerous, when hospitals themselves seem like sources of contagion, that becomes an act of courage.
Notable Quotes
Women diagnosed with breast cancer must take precautions against coronavirus, but should not interrupt treatment without consulting their medical team— Dr. Cleverson Gomes do Carmo Junior, breast surgeon
Women should perform self-examination by feeling for lumps, checking for skin changes, and watching for nipple discharge— Dr. Cleverson Gomes do Carmo Junior
The Hearth Conversation Another angle on the story
Why does October specifically become the month for this campaign? Is there something about breast cancer that peaks then?
No, there's nothing seasonal about the disease itself. October was chosen as a symbolic month for awareness globally. The pink ribbon became the symbol, and the month became the moment when hospitals and health systems could concentrate their messaging. It's a way of saying: this matters, pay attention now.
The doctor mentions that women are avoiding treatment because of the pandemic. How widespread is that problem?
He doesn't give exact numbers, but the concern is real enough that he felt compelled to address it directly. The fear is understandable—hospitals are dangerous places in 2020. But delaying cancer treatment is its own kind of danger, one that compounds over time.
The cure rate drops significantly if detection is delayed, doesn't it?
Dramatically. Over 90 percent when caught early. But that number falls as the cancer progresses. Every month of delay matters. That's why the self-exam recommendation starts so young—age 21—and why mammography becomes routine at 40.
Is self-examination actually reliable, or is that just something doctors tell women to do?
It's not a substitute for professional screening, but it's not nothing either. Women know their own bodies. They notice changes. The point is to create a habit of attention, so that something genuinely abnormal gets caught and brought to a doctor.
What strikes you most about the 790 number for Espírito Santo?
That it's specific. It's not abstract. It means 790 women in one state will hear a diagnosis this year. Some will catch it early and survive. Others won't. The campaign exists because that gap—between early detection and late detection—is where lives are saved or lost.